Request for Educational (RFE) Support: Non-valvular Atrial Fibrillation (NVAF) and Real World Evidence (RWE)

Funding Agency:
Bristol-Myers Squibb

The intent of this RFE is to identify and support activities designed to increase understanding around the methodology, generation, quality, and utility of real world data. It also should address the use of real world evidence in comparing safety and effectiveness associated with the use of different oral anticoagulant therapy for reduction of stroke risk in patients with NVAF.

Deadline: Apr. 10, 2019

Agency Website

Eligibility Requirements

Geographic Scope: United States and Canada ONLY

Amount

$150,000

Funding Type

Grant

Eligibility

Faculty

Category

Curriculum Development
Medical
Medical - Clinical Science

External Deadline

April 10, 2019